Impact of Combined “CHADS-BLED” Score to Predict Short-Term Outcomes in Transfemoral and Transapical Aortic Valve Replacement

Table 1

Discrimination performance (ROC and AUC statistics): all-comers.

Groups/endpoints	Variables	AUC	value	Lower 95% CI	Upper 95% CI
(A) TF TAVR
30-day mortality	Log. EuroSCORE I	0.53	0.535	0.42	0.64
	STS score	0.68	0.001	0.59	0.76
	CHA2DS2-VASC	0.57	0.162	0.47	0.68
	HAS-BLED	0.58	0.132	0.46	0.69
	“CHADS-BLED”	0.60	0.058	0.49	0.71
CVI	Log. EuroSCORE I	0.53	0.488	0.49	0.61
	STS score	0.59	0.022	0.52	0.67
	CHA2DS2-VASC	0.60	0.015	0.53	0.67
	HAS-BLED	0.66	<0.0001	0.58	0.74
	“CHADS-BLED”	0.66	<0.0001	0.58	0.73
MVASC/BARC	Log. EuroSCORE I	0.55	0.246	0.46	0.64
	STS score	0.65	<0.0001	0.58	0.73
	CHA2DS2-VASC	0.54	0.319	0.47	0.62
	HAS-BLED	0.59	0.035	0.51	0.68
	“CHADS-BLED”	0.59	0.048	0.50	0.67
(B) TA TAVR
30-day mortality	Log. EuroSCORE I	0.66	0.005	0.56	0.77
	STS score	0.64	0.016	0.55	0.73
	CHA2DS2-VASC	0.53	0.559	0.43	0.64
	HAS-BLED	0.58	0.157	0.47	0.70
	“CHADS-BLED”	0.57	0.217	0.46	0.68
CVI	Log. EuroSCORE I	0.41	0.240	0.29	0.54
	STS score	0.41	0.244	0.28	0.55
	CHA2DS2-VASC	0.64	0.054	0.52	0.76
	HAS-BLED	0.53	0.725	0.36	0.69
	“CHADS-BLED”	0.60	0.174	0.46	0.74
MVASC/BARC	Log. EuroSCORE I	0.53	0.598	0.44	0.61
	STS score	0.56	0186	0.48	0.65
	CHA2DS2-VASC	0.53	0.490	0.44	0.63
	HAS-BLED	0.49	0.866	0.39	0.59
	“CHADS-BLED”	0.54	0.462	0.44	0.63